08/11/2024  17:32:00 Var. -0.40 Volume Denaro17:32:00 Lettera17:32:00 Capitalizzazione di mercato Dividend Y. Rapporto P/E
79.13CHF -0.50% 497,631
Fatturato: 39.46 mill.
-Quantità in denaro: - -Quantità in lettera: - 210.88 bill.CHF 3.80% 18.63

Descrizione business

Nestlé is a science-based Nutrition, Health and Wellness company. The creation of Nestlé Health Science S.A. and the Nestlé Institute of Health Sciences reinforced this strategic direction and focus on helping consumers lead a healthier life through nutritional solutions from food and beverages to life-enhancing scientific products. Responding to increasing consumer needs, Nestlé extended its activities to include the field of specialized, medical skin treatments through the creation of Nestlé Skin Health S.A., a global leader focused on meeting the world’s increasing skin health needs with a broad range of innovative and scientifically-proven products.
 

Consiglio di amministrazione & Consiglio di sorveglianza

CEO
Laurent Freixe
Consiglio di amministrazione
Anna Manz, Béatrice Guillaume-Grabisch, David Rennie, Laurent Freixe, Leanne Geale, Sanjay Bahadur, Steven Wood Presley, Remy Ejel , David Xiqiang Zhang, Stefan Palzer, Bernard Meunier, Stephanie Pullings Hart, Anna Mohl, Guillaume Le Cunff, Lisa Gibby
Consiglio di sorveglianza
Paul Bulcke, Dick Boer, Dinesh Paliwal, Hanne Jimenez de Mora, Lindiwe Majele Sibanda, Patrick Aebischer, Renato Fassbind, Luca Maestri, Chris Leong, Geraldine Matchett, Rainer Blair, Marie-Gabrielle Ineichen-Fleisch, Pablo Isla
 

Dati aziendali

Name: Nestlé SA
Indirizzo: Avenue Nestlé 55,Vevey
Telefono: +41-21-924-1111
Fax: +41-21-924-4800
E-mail: -
Internet: www.nestle.com/
Industria: Consumer Goods
Settore: Food and Beverage
Sub settore: Food Products
Fine dell'anno finanziario: 31/12
Flottante libero: 96.83%
Data dell'IPO: 25/10/1905

Rapporti con gli investitori

Name: David Hancock
IR telefono: +41 21 924 3509
IR Fax: +41 (21) 924 4800
IR e-mail: ir@nestle.com

Company calendar

CW 7 | 13/02/2025 Report 4th Quarter
CW 16 | 16/04/2025 General Shareholder Meeting
 

Principali azionisti

Altri
 
94.96%
BlackRock, Inc.
 
5.04%